Restructuring of foreign-invested pharmaceutical firms eyed

Influenced by the overall business setbacks in the domestic pharmaceutical sector due to debt-ridden finance of the National Health Insurance Corporation and other unfavorable factor in next year, foreign-invested pharmaceutical firms are likely to accelerate their restructuring programs amid the failure of the projected sales target this year.

Pharmaceutical business sources say that with t...